As depicted in Figure 1, Id-specific TCR-transgenic mice are protected against MOPC315 tumors [17], and the primary anti-tumor immune response in these mice is mediated by the Id-specific TCR- transgenic CD4+ T cells [19]. This evidence concerns the gene CD4 and neoplasm.